BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 6323951)

  • 1. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1284-91. PubMed ID: 6095979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer modeling of subtypes of kappa opioid receptors in adrenal medulla.
    Pesce GO; Cruciani RA; Munson PJ; Rodbard D
    Eur J Pharmacol; 1990 Jul; 182(3):429-39. PubMed ID: 2171945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
    NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of adrenal medullary opioid receptors. I. Binding of opioids to adrenal medullary opioid receptors].
    Murase H; Kamikubo K; Murayama M; Yasuda K; Tsurumi K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 Jun; 63(6):727-40. PubMed ID: 2822499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
    Kooper GN; Levinson NR; Copeland CF; Bowen WD
    Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of kappa opioid receptors in neurosecretosomes from bovine posterior pituitary.
    Pesce G; Lang MA; Russell JT; Rodbard D; Gainer H
    J Neurochem; 1987 Aug; 49(2):421-7. PubMed ID: 3037028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoaffinity crosslinking of etorphine with opioid binding sites in the bovine adrenal medulla.
    Cantau P; Bourhim N; Giraud P; Oliver C; Castanas E
    Biotechnol Appl Biochem; 1987 Apr; 9(2):114-22. PubMed ID: 3036179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF; Goldstein A
    Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of opiate binding sites in kidney and adrenal gland of the rat.
    Quirion R; Finkel MS; Mendelsohn FA; Zamir N
    Life Sci; 1983; 33 Suppl 1():299-302. PubMed ID: 6319881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A; Bakogeorgou E; Castanas E
    Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of dynorphin with kappa opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Neuropeptides; 1985 Jul; 6(4):321-9. PubMed ID: 2864653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites.
    Spain JW; Petta DE; Coscia CJ
    Mol Pharmacol; 1988 Jul; 34(1):23-8. PubMed ID: 2839762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.